Last update 01 Nov 2024

PL-9643

Overview

Basic Info

Drug Type
Biological products
Synonyms
PL 9643
Mechanism
MC1R agonists(Melanocortin receptor 1 agonists), MC5R agonists(Melanocortin receptor 5 agonists)
Therapeutic Areas
Active Indication-
Originator Organization
Active Organization-
Drug Highest PhasePendingPhase 3
First Approval Date-
Regulation-
Login to view timeline

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
XerophthalmiaPhase 3
US
28 Dec 2021
Dry Eye SyndromesPhase 2
US
14 Feb 2020
Retinal DiseasesPreclinical
US
17 Sep 2021
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
575
pnpatvoewp(eedwtvtrby) = frjjbosbjr chfetnauld (htisdkqypy )
Positive
08 Apr 2024
Phase 3
575
PL9643
nohawzefdi(zhbjrnexzh): P-Value = < 0.025
Met
Positive
28 Mar 2024
vehicle
Phase 2
160
rjrrtfubbm(zmiobjeqlc) = sxjjoqltvn weypszyxbm (cdybulprxt, –0.97 - −0.58)
Negative
07 Sep 2023
Placebo
rjrrtfubbm(zmiobjeqlc) = qfsuoxijir weypszyxbm (cdybulprxt, –0.86 - −0.47)
Phase 3
120
rsnivatfsp(dacfbdjqfp) = The emerging data, including the safety and ocular tolerability, indicate that PL9643 could be a potentially safe and effective treatment for patients with DED xogzmfkiog (yfmenpftlb )
Positive
16 Aug 2022
Vehicle
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free